POSA223 Dynamics of EU Market Exclusivity: The Impact of Orphan Designation on Generic or Biosimilar Entry
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.696
https://www.valueinhealthjournal.com/article/S1098-3015(21)02491-8/fulltext
Title :
POSA223 Dynamics of EU Market Exclusivity: The Impact of Orphan Designation on Generic or Biosimilar Entry
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02491-8&doi=10.1016/j.jval.2021.11.696
First page :
Section Title :
Open access? :
No
Section Order :
10233